Get Premium to unlock powerful stock data
HOOKIPA Pharma Inc logo

HOOKIPA Pharma Inc

$ 1.40 0 (0%) 09:40 AM EST
P/E:
At Loss
P/B:
0.50
Market Cap:
$ 76.57M
Enterprise V:
$ 19.63M
Volume:
401.55K
Avg Vol (2M):
1.09M
Volume:
401.55K
Market Cap $:
76.57M
PE Ratio:
At Loss
Avg Vol (2-Month):
1.09M
Enterprise Value $:
19.63M
PB Ratio:
0.50
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

HOOKIPA Pharma Inc
NAICS : 325412 SIC : 2834
350 Fifth Avenue, 72nd Floor, Suite 7240, New York, NY, USA, 10118
Description
HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.
Name Current Vs Industry Vs History
Cash-To-Debt 6.2
Equity-to-Asset 0.71
Debt-to-Equity 0.12
Debt-to-EBITDA -0.15
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -2.34
Distress
Grey
Safe
Beneish M-Score -2.63
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 45.29
9-Day RSI 42.03
14-Day RSI 41.91
6-1 Month Momentum % -53.26
12-1 Month Momentum % -89.81

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.69
Quick Ratio 3.69
Cash Ratio 2.38
Days Sales Outstanding 95.62

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -7.1

Financials (Next Earnings Date:2022-08-12 Est.)

HOOK's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:HOOK

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Performance
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 18.448
EPS (TTM) ($) -2.31
Beta 0.83
Volatility % 99.2
14-Day RSI 41.91
14-Day ATR ($) 0.146517
20-Day SMA ($) 1.498
12-1 Month Momentum % -89.81
52-Week Range ($) 1.25 - 20
Shares Outstanding (Mil) 54.69

Piotroski F-Score Details

Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

HOOKIPA Pharma Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More